(Q42287076)

English

PD 141955 and CI-972: 9-deazaguanine analog purine nucleoside phosphorylase inhibitors. II. Effects on nucleoside catabolism in human and rat blood in vitro

scientific article published on January 1993

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PD 141955 and CI-972: 9-deazaguanine analog purine nucleoside phosphorylase inhibitors. II. Effects on nucleoside catabolism in human and rat blood in vitro (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

author name string

M K Dong

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

R B Gilbertsen

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

publication date

1 January 1993

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Agents and Actions

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

39 Spec No

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

C99-101

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Clearance and biologic half-life as indices of intrinsic hepatic metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/8273600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical and Pharmacological Properties of CI-972, a Novel 9-Deazaguanine Analog Purine Nucleoside Phosphorylase (PNP) Inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/8273600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dipyridamole and 8-aminoguanosine inhibition of nucleoside metabolism in rat blood in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/8273600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective in vitro inhibition of human MOLT-4 T lymphoblasts by the novel purine nucleoside phosphorylase inhibitor, CI-972

1 reference

https://pubmed.ncbi.nlm.nih.gov/8273600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Application of crystallographic and modeling methods in the design of purine nucleoside phosphorylase inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/8273600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibitors of human purine nucleoside phosphorylase. Synthesis of pyrrolo[3,2-d]pyrimidines, a new class of purine nucleoside phosphorylase inhibitors as potentially T-cell selective immunosuppressive agents. Description of 2,6-diamino-3,5-dihydro-7

1 reference

https://pubmed.ncbi.nlm.nih.gov/8273600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PD 141955 and CI-972: 9-deazaguanine analog purine nucleoside phosphorylase inhibitors. I. Suppression of the human mixed lymphocyte reaction (MLR).

1 reference

https://pubmed.ncbi.nlm.nih.gov/8273600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative in vitro and in vivo activities of two 9-deazaguanine analog inhibitors of purine nucleoside phosphorylase, CI-972 and PD 141955

1 reference

https://pubmed.ncbi.nlm.nih.gov/8273600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01972733

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42287076&oldid=1941287027"